Close Menu

NEW YORK – Mobidiag today announced that it has signed an exclusive agreement with Pro Med Diagnostics for the distribution of its Amplidiag and Novodiag products in African countries, including South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Malawi, Kenya, and Uganda.

Tuomas Tenkanen, CEO of Mobidiag, said in a statement that Africa "represents a fast growing market for diagnostic products with enormous growth potential."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.